Advertisement

Topics

Post-2017 sale of STING agonists to BMS, IFM launches new subsidiary to develop STING antagonists. more from @RLCscienceboss : https://cen.acs.org/business/IFM-Therapeutics-looks-inhibit-STING/97/web/2019/02 …

08:36 EST 11 Feb 2019 | Odi Bruckman

Post-2017 sale of STING agonists to BMS, IFM launches new subsidiary to develop STING antagonists. more from : https://cen.acs.org/business/IFM-Therapeutics-looks-inhibit-STING/97/web/2019/02 …

Original Article: Post-2017 sale of STING agonists to BMS, IFM launches new subsidiary to develop STING antagonists. more from @RLCscienceboss : https://cen.acs.org/business/IFM-Therapeutics-looks-inhibit-STING/97/web/2019/02 …

NEXT ARTICLE

More From BioPortfolio on "Post-2017 sale of STING agonists to BMS, IFM launches new subsidiary to develop STING antagonists. more from @RLCscienceboss : https://cen.acs.org/business/IFM-Therapeutics-looks-inhibit-STING/97/web/2019/02 …"

Advertisement
Quick Search
Advertisement
Advertisement